HEADER HYDROLASE/HYDROLASE INBITITOR 21-OCT-14 4RMG TITLE HUMAN SIRT2 IN COMPLEX WITH SIRREAL2 AND NAD+ COMPND MOL_ID: 1; COMPND 2 MOLECULE: NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-2; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 56-356; COMPND 5 SYNONYM: REGULATORY PROTEIN SIR2 HOMOLOG 2, SIR2-LIKE PROTEIN 2; COMPND 6 EC: 3.5.1.-; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: SIRT2, SIR2L, SIR2L2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS HYDROLASE-HYDROLASE INBITITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR T.RUMPF,M.SCHIEDEL,B.KARAMAN,C.ROESSLER,B.J.NORTH,A.LEHOTZKY,J.OLAH, AUTHOR 2 K.I.LADWEIN,K.SCHMIDTKUNZ,M.GAJER,M.PANNEK,C.STEEGBORN,D.A.SINCLAIR, AUTHOR 3 S.GERHARDT,J.OVADI,M.SCHUTKOWSKI,W.SIPPL,O.EINSLE,M.JUNG REVDAT 2 28-FEB-24 4RMG 1 REMARK SEQADV LINK REVDAT 1 25-FEB-15 4RMG 0 JRNL AUTH T.RUMPF,M.SCHIEDEL,B.KARAMAN,C.ROESSLER,B.J.NORTH, JRNL AUTH 2 A.LEHOTZKY,J.OLAH,K.I.LADWEIN,K.SCHMIDTKUNZ,M.GAJER, JRNL AUTH 3 M.PANNEK,C.STEEGBORN,D.A.SINCLAIR,S.GERHARDT,J.OVADI, JRNL AUTH 4 M.SCHUTKOWSKI,W.SIPPL,O.EINSLE,M.JUNG JRNL TITL SELECTIVE SIRT2 INHIBITION BY LIGAND-INDUCED REARRANGEMENT JRNL TITL 2 OF THE ACTIVE SITE. JRNL REF NAT COMMUN V. 6 6263 2015 JRNL REFN ESSN 2041-1723 JRNL PMID 25672491 JRNL DOI 10.1038/NCOMMS7263 REMARK 2 REMARK 2 RESOLUTION. 1.88 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0049 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.88 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 48.28 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 30694 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.205 REMARK 3 R VALUE (WORKING SET) : 0.202 REMARK 3 FREE R VALUE : 0.247 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1640 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.88 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.93 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2249 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.96 REMARK 3 BIN R VALUE (WORKING SET) : 0.3170 REMARK 3 BIN FREE R VALUE SET COUNT : 117 REMARK 3 BIN FREE R VALUE : 0.3940 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2350 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 74 REMARK 3 SOLVENT ATOMS : 99 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 37.89 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.18000 REMARK 3 B22 (A**2) : 1.65000 REMARK 3 B33 (A**2) : 0.29000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.95000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.135 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.136 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.124 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 8.613 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.959 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.940 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2486 ; 0.014 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 2336 ; 0.003 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3360 ; 1.651 ; 1.974 REMARK 3 BOND ANGLES OTHERS (DEGREES): 5393 ; 0.870 ; 3.001 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 294 ; 6.400 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 105 ;35.347 ;23.810 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 430 ;14.347 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 14 ;16.589 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 361 ; 0.095 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2949 ; 0.008 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 555 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1188 ; 2.238 ; 2.618 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1188 ; 2.230 ; 2.617 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1477 ; 3.369 ; 3.897 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 1478 ; 3.368 ; 3.897 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1298 ; 2.690 ; 2.995 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 1299 ; 2.689 ; 2.995 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 1884 ; 4.177 ; 4.390 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 2823 ; 6.341 ;21.688 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 2790 ; 6.340 ;21.536 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 2 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 54 A 356 REMARK 3 RESIDUE RANGE : A 401 A 401 REMARK 3 ORIGIN FOR THE GROUP (A): -16.2157 -26.2576 0.3601 REMARK 3 T TENSOR REMARK 3 T11: 0.0497 T22: 0.1813 REMARK 3 T33: 0.0455 T12: 0.0887 REMARK 3 T13: 0.0468 T23: 0.0877 REMARK 3 L TENSOR REMARK 3 L11: 0.4407 L22: 0.4122 REMARK 3 L33: 0.6591 L12: 0.3083 REMARK 3 L13: 0.2429 L23: -0.1510 REMARK 3 S TENSOR REMARK 3 S11: -0.0298 S12: -0.0229 S13: -0.0105 REMARK 3 S21: -0.0697 S22: -0.0398 S23: -0.0459 REMARK 3 S31: 0.0604 S32: 0.0498 S33: 0.0696 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 4RMG COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 23-OCT-14. REMARK 100 THE DEPOSITION ID IS D_1000087527. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 22-OCT-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-007 HF REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : VARIMAX VHF FOCUSING MIRRORS REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MAR SCANNER 345 MM PLATE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 32335 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.880 REMARK 200 RESOLUTION RANGE LOW (A) : 75.130 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.500 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.88 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.92 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 57.71 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.91 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M KSCN, 30% (WT/VOL) PEG MME REMARK 280 2,000, PH 8.0, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z+1/2 REMARK 290 4555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 21.55614 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 27.25700 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 43.88078 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 21.55614 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 27.25700 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 43.88078 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 7510 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 25000 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -43.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 53 REMARK 465 SER A 100 REMARK 465 THR A 101 REMARK 465 GLY A 102 REMARK 465 PRO A 295 REMARK 465 PHE A 296 REMARK 465 LEU A 297 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 HIS A 54 CG ND1 CD2 CE1 NE2 REMARK 470 ARG A 97 CG CD NE CZ NH1 NH2 REMARK 470 SER A 293 OG REMARK 470 ASP A 294 CG OD1 OD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 97 -162.29 -74.21 REMARK 500 ASP A 231 33.98 -74.97 REMARK 500 PRO A 277 150.95 -44.75 REMARK 500 MET A 301 -112.58 43.66 REMARK 500 ARG A 316 -3.76 -147.85 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 401 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS A 195 SG REMARK 620 2 CYS A 200 SG 111.4 REMARK 620 3 CYS A 221 SG 111.2 112.0 REMARK 620 4 CYS A 224 SG 93.3 117.8 109.7 REMARK 620 N 1 2 3 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 3TE A 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAD A 403 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4RMH RELATED DB: PDB REMARK 900 RELATED ID: 4RMI RELATED DB: PDB REMARK 900 RELATED ID: 4RMJ RELATED DB: PDB DBREF 4RMG A 56 356 UNP Q8IXJ6 SIR2_HUMAN 56 356 SEQADV 4RMG GLY A 53 UNP Q8IXJ6 EXPRESSION TAG SEQADV 4RMG HIS A 54 UNP Q8IXJ6 EXPRESSION TAG SEQADV 4RMG MET A 55 UNP Q8IXJ6 EXPRESSION TAG SEQRES 1 A 304 GLY HIS MET GLU ARG LEU LEU ASP GLU LEU THR LEU GLU SEQRES 2 A 304 GLY VAL ALA ARG TYR MET GLN SER GLU ARG CYS ARG ARG SEQRES 3 A 304 VAL ILE CYS LEU VAL GLY ALA GLY ILE SER THR SER ALA SEQRES 4 A 304 GLY ILE PRO ASP PHE ARG SER PRO SER THR GLY LEU TYR SEQRES 5 A 304 ASP ASN LEU GLU LYS TYR HIS LEU PRO TYR PRO GLU ALA SEQRES 6 A 304 ILE PHE GLU ILE SER TYR PHE LYS LYS HIS PRO GLU PRO SEQRES 7 A 304 PHE PHE ALA LEU ALA LYS GLU LEU TYR PRO GLY GLN PHE SEQRES 8 A 304 LYS PRO THR ILE CYS HIS TYR PHE MET ARG LEU LEU LYS SEQRES 9 A 304 ASP LYS GLY LEU LEU LEU ARG CYS TYR THR GLN ASN ILE SEQRES 10 A 304 ASP THR LEU GLU ARG ILE ALA GLY LEU GLU GLN GLU ASP SEQRES 11 A 304 LEU VAL GLU ALA HIS GLY THR PHE TYR THR SER HIS CYS SEQRES 12 A 304 VAL SER ALA SER CYS ARG HIS GLU TYR PRO LEU SER TRP SEQRES 13 A 304 MET LYS GLU LYS ILE PHE SER GLU VAL THR PRO LYS CYS SEQRES 14 A 304 GLU ASP CYS GLN SER LEU VAL LYS PRO ASP ILE VAL PHE SEQRES 15 A 304 PHE GLY GLU SER LEU PRO ALA ARG PHE PHE SER CYS MET SEQRES 16 A 304 GLN SER ASP PHE LEU LYS VAL ASP LEU LEU LEU VAL MET SEQRES 17 A 304 GLY THR SER LEU GLN VAL GLN PRO PHE ALA SER LEU ILE SEQRES 18 A 304 SER LYS ALA PRO LEU SER THR PRO ARG LEU LEU ILE ASN SEQRES 19 A 304 LYS GLU LYS ALA GLY GLN SER ASP PRO PHE LEU GLY MET SEQRES 20 A 304 ILE MET GLY LEU GLY GLY GLY MET ASP PHE ASP SER LYS SEQRES 21 A 304 LYS ALA TYR ARG ASP VAL ALA TRP LEU GLY GLU CYS ASP SEQRES 22 A 304 GLN GLY CYS LEU ALA LEU ALA GLU LEU LEU GLY TRP LYS SEQRES 23 A 304 LYS GLU LEU GLU ASP LEU VAL ARG ARG GLU HIS ALA SER SEQRES 24 A 304 ILE ASP ALA GLN SER HET ZN A 401 1 HET 3TE A 402 29 HET NAD A 403 44 HETNAM ZN ZINC ION HETNAM 3TE 2-[(4,6-DIMETHYLPYRIMIDIN-2-YL)SULFANYL]-N-[5- HETNAM 2 3TE (NAPHTHALEN-1-YLMETHYL)-1,3-THIAZOL-2-YL]ACETAMIDE HETNAM NAD NICOTINAMIDE-ADENINE-DINUCLEOTIDE FORMUL 2 ZN ZN 2+ FORMUL 3 3TE C22 H20 N4 O S2 FORMUL 4 NAD C21 H27 N7 O14 P2 FORMUL 5 HOH *99(H2 O) HELIX 1 1 THR A 63 SER A 73 1 11 HELIX 2 2 ALA A 85 GLY A 92 5 8 HELIX 3 3 TYR A 104 GLU A 108 1 5 HELIX 4 4 LYS A 109 HIS A 111 5 3 HELIX 5 5 TYR A 114 PHE A 119 5 6 HELIX 6 6 GLU A 120 HIS A 127 1 8 HELIX 7 7 PRO A 128 TYR A 139 1 12 HELIX 8 8 THR A 146 LYS A 158 1 13 HELIX 9 9 THR A 171 ALA A 176 1 6 HELIX 10 10 GLU A 179 GLU A 181 5 3 HELIX 11 11 LEU A 206 GLU A 216 1 11 HELIX 12 12 PRO A 240 VAL A 254 1 15 HELIX 13 13 PRO A 268 ILE A 273 1 6 HELIX 14 14 SER A 274 ALA A 276 5 3 HELIX 15 15 ILE A 300 GLY A 304 5 5 HELIX 16 16 GLU A 323 GLY A 336 1 14 HELIX 17 17 TRP A 337 GLN A 355 1 19 SHEET 1 A 6 LEU A 183 GLU A 185 0 SHEET 2 A 6 LEU A 161 THR A 166 1 N THR A 166 O VAL A 184 SHEET 3 A 6 VAL A 79 VAL A 83 1 N CYS A 81 O TYR A 165 SHEET 4 A 6 LEU A 256 MET A 260 1 O LEU A 258 N ILE A 80 SHEET 5 A 6 ARG A 282 ASN A 286 1 O LEU A 283 N VAL A 259 SHEET 6 A 6 ASP A 317 LEU A 321 1 O TRP A 320 N LEU A 284 SHEET 1 B 3 GLU A 203 PRO A 205 0 SHEET 2 B 3 GLY A 188 CYS A 195 -1 N SER A 193 O TYR A 204 SHEET 3 B 3 VAL A 228 ILE A 232 -1 O ASP A 231 N THR A 192 LINK SG CYS A 195 ZN ZN A 401 1555 1555 2.34 LINK SG CYS A 200 ZN ZN A 401 1555 1555 2.24 LINK SG CYS A 221 ZN ZN A 401 1555 1555 2.31 LINK SG CYS A 224 ZN ZN A 401 1555 1555 2.33 CISPEP 1 GLN A 267 PRO A 268 0 9.02 SITE 1 AC1 4 CYS A 195 CYS A 200 CYS A 221 CYS A 224 SITE 1 AC2 14 PHE A 96 ILE A 118 PHE A 119 PHE A 131 SITE 2 AC2 14 ALA A 135 TYR A 139 PRO A 140 ASP A 170 SITE 3 AC2 14 PHE A 190 ILE A 232 VAL A 233 PHE A 234 SITE 4 AC2 14 MET A 299 HOH A 540 SITE 1 AC3 26 GLY A 84 ALA A 85 GLY A 86 THR A 89 SITE 2 AC3 26 ILE A 93 PRO A 94 ASP A 95 PHE A 96 SITE 3 AC3 26 GLN A 167 ASN A 168 ILE A 169 ASP A 170 SITE 4 AC3 26 HIS A 187 GLY A 261 THR A 262 SER A 263 SITE 5 AC3 26 ASN A 286 LYS A 287 GLU A 288 MET A 299 SITE 6 AC3 26 GLY A 322 GLU A 323 CYS A 324 HOH A 501 SITE 7 AC3 26 HOH A 502 HOH A 558 CRYST1 83.701 54.514 96.693 90.00 114.82 90.00 I 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011947 0.000000 0.005526 0.00000 SCALE2 0.000000 0.018344 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011395 0.00000